Infertility treatment may represent a paradigmatic example of precision medicine. Follicle-stimulating hormone (FSH) has been proposed as a valuable therapeutic option both in males and in females, even if a standardized approach is far to be established. To date, several genetic mutations as well as polymorphisms have been demonstrated to significantly affect the pathophysiology of FSH-FSH receptor (FSHR) interaction, although the underlying molecular mechanisms remain unclear. This review aims to highlight possible aspects of FSH therapy that could benefit from a pharmacogenetic approach, providing an up-to-date overview of the variability of the response to FSH treatment in both sexes. Specific sections are dedicated to the clinical use of FSH in infertility and how FSHR polymorphisms may affect the therapeutic endpoints.

Pharmacogenetics of G-protein-coupled receptors variants: FSH receptor and infertility treatment / Santi, Daniele; Potì, Francesco; Simoni, Manuela; Casarini, Livio. - In: BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL ENDOCRINOLOGY & METABOLISM. - ISSN 1521-690X. - 32:2(2018), pp. 189-200. [10.1016/j.beem.2018.01.001]

Pharmacogenetics of G-protein-coupled receptors variants: FSH receptor and infertility treatment

Santi, Daniele;Potì, Francesco;Simoni, Manuela;Casarini, Livio
2018

Abstract

Infertility treatment may represent a paradigmatic example of precision medicine. Follicle-stimulating hormone (FSH) has been proposed as a valuable therapeutic option both in males and in females, even if a standardized approach is far to be established. To date, several genetic mutations as well as polymorphisms have been demonstrated to significantly affect the pathophysiology of FSH-FSH receptor (FSHR) interaction, although the underlying molecular mechanisms remain unclear. This review aims to highlight possible aspects of FSH therapy that could benefit from a pharmacogenetic approach, providing an up-to-date overview of the variability of the response to FSH treatment in both sexes. Specific sections are dedicated to the clinical use of FSH in infertility and how FSHR polymorphisms may affect the therapeutic endpoints.
2018
31-gen-2018
32
2
189
200
Pharmacogenetics of G-protein-coupled receptors variants: FSH receptor and infertility treatment / Santi, Daniele; Potì, Francesco; Simoni, Manuela; Casarini, Livio. - In: BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL ENDOCRINOLOGY & METABOLISM. - ISSN 1521-690X. - 32:2(2018), pp. 189-200. [10.1016/j.beem.2018.01.001]
Santi, Daniele; Potì, Francesco; Simoni, Manuela; Casarini, Livio
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1521690X18300010-main.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 946.09 kB
Formato Adobe PDF
946.09 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1164916
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 16
social impact